— Know what they know.
Not Investment Advice

INGN NASDAQ

Inogen, Inc.
1W: -5.7% 1M: -10.3% 3M: +10.7% YTD: -3.3% 1Y: +2.2% 3Y: -40.9% 5Y: -90.3%
$6.40
-0.01 (-0.16%)
 
Weekly Expected Move ±6.0%
$6 $6 $6 $7 $7
NASDAQ · Healthcare · Medical - Devices · Alpha Radar Sell · Power 30 · $173.3M mcap · 24M float · 1.41% daily turnover · Short 47% of daily vol

Revenue Segmentation

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$349M +3.9% ▲
5Y CAGR: +2.5%
Gross Profit
$166M +7.2% ▲
5Y CAGR: +3.7%
Operating Income
-$30M +29.0% ▲
Net Income
-$23M +36.6% ▲
EPS (Diluted)
$-0.85 +44.1% ▲
EBITDA
-$3M +87.4% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$358M$377M$316M$336M$349M
YoY Growth+16.1%+5.4%-16.3%+6.4%+3.9%
Cost of Revenue$182M$224M$189M$181M$183M
Gross Profit$176M$154M$127M$155M$166M
Gross Margin49.3%40.7%40.1%46.1%47.6%
R&D Expenses$17M$22M$21M$22M$19M
SG&A Expenses$151M$165M$182M$176M$165M
Operating Expenses$167M$239M$236M$197M$196M
Operating Income$9M-$85M-$109M-$43M-$30M
Operating Margin2.6%-22.6%-34.7%-12.7%-8.7%
Interest Expense$0$0$0$0$0
Income Before Tax$9M-$83M-$102M-$36M-$23M
Tax Expense$15M$504K$105K-$588K-$632K
Net Income-$6M-$84M-$102M-$36M-$23M
Net Margin-1.8%-22.2%-32.5%-10.7%-6.5%
EPS (Diluted)$-0.28$-3.67$-4.42$-1.52$-0.85
EBITDA$31M-$10M-$58M-$22M-$3M
Shares Outstanding22M23M23M24M27M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms